Media release: CLINUVEL Trial Results Show Drug Reduces DNA Damage 2023 Announcements . Clinical . Regulatory 16.01.2023
Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum – Technical Note 2023 Announcements . Clinical . Regulatory 16.01.2023
Afamelanotide Reduces DNA Photodamage in Xeroderma Pigmentosum 2023 Announcements . Clinical . Regulatory 16.01.2023
First vitiligo patient enrolled in afamelanotide monotherapy study 2022 Announcements . Clinical . Regulatory 20.10.2022
CLINUVEL submits SCENESSE® label expansion for adolescent EPP patients 2022 Announcements . Clinical . Regulatory 05.09.2022
First XP-V Patient Treated in CLINUVEL DNA Repair Study 2022 Announcements . Clinical . News 30.03.2022
Afamelanotide in stroke (AIS) – positive preliminary results 2022 Announcements . Clinical . News 15.03.2022